mention of asbestos-like bodies in describing the effects in the lung of inhaled glass wool fibres in two animal species, including a species which consistently forms asbestos bodies when exposed to asbestos dust. There are few reports in the literature on the effects of glass fibre in man, but Murphy,5 in a human case of " fibre-glass pneumoconiosis," describes and illustrates numerous uncoated glass fibres in the lung tissues without mentioning asbestos-like bodies. It is also likely that, as used in industrial conditions, much of the dust derived from glass fibres consists of particles too large to be respirable.' For these reasons I consider it is very unlikely that any of the "asbestos bodies" in my series can be attributed to glass fibres.
The role of diatomaceous earth is likewise doubtful. Vigliani and Mottura' describe in detail the post-mortem histological appearances in the lungs of a man exposed to pure calcined diatomite dust without mentioning asbestos-like bodies. That they were aware of the possibility of finding such bodies is clear from their reference to the work of Nordmann,' who described asbestos-like bodies in lung tissue at necropsy in patients exposed to diatomaceous earth and quartz dust. Nordmann, however, is careful to distinguish between " pseudoasbestos bodies " present in two of his six cases and "true asbestos bodies " found in another two cases known to have been exposed to Thus within a few days of discontinuing guanethidine the requirements of insulin had increased considerably. Since there was no other change in treatment or general condition of the patient., such as acute infection, the stoppage of guanethidine appears to have been responsible for this increase in blood sugar levels and increased insulin requirements. There is no published report on the effect of guanethidine on severity of diabetes. However, Woeber et al. reported reversal by guanethidine of abnormal glucose tolerance in patients with thyrotoxicosis.1 In rats, guanethidine 20 mg./kg. intraperitoneally daily for four days produced a slight fall in blood sugar. Chronic pretreatment with guanethidine in a dose of 20 mg./kg. daily has been found to modify the hyperglycaemic response to ether anaesthesia. The maximum increase in blood sugar was diminished, but the overall rise appeared to be somewhat prolonged.23 In rabbits, on the other hand, Parikh et al.4 showed a hyperglycaemic action of guanethidine and also that it potentiated the hyperglycaemic action of epinephrine in a smaller dose, which itself had no effect on blood sugar. Intravenous administration of guanethidine 0.4 mg./kg. in seven patients with hypertension was found to cause slight hyperglycaemia after three hours.5 Guanethidine causes release of epinephrine, and epinephrine has been experimentally shown to inhibit pancreatic Insulin release.6 However, the results of chronic administration of guanethidine, when tissues are depleted of epinephrine, may well be different from this acute effect. Guanethidine significantly reduced the hyperglycaemic response to diazoxide in adrenal demedullated rats.7
This last finding may have some relevance to the present case, since she had been on bendrofluazide S mg. daily for the last six months. It is possible that guanethidine was blocking the hyperglycaemic action of bendrofluazide, which became manifest dramatically when the former was discontinued. This case is being reported as an interesting clinical observation. Deaths from Asthma SIR,-I have followed the correspondence on deaths from asthma with interest, and I am grateful to Drs. I. W. B. Grant and others (18 May, p. 429) for their oonments on four cases of cardiac arrest due to status asthmaticus occurring in hospital. However, their statement that "when a patient with status asthmaticus develops cardiac arrest in hospital and this is shown to be due to ventricular asystole the proper course is to undertake open cardiac massage without delay " appears to be rather dogmatic. My experience of one case is reported below, in which the conventional conservative measures for the treatment of asystole were effectivenamely, intracardiac adrenaline (1:10,000) with or without calcium chloride 10% intravenously.
A female asthmatic aged 44 years was readmitted with status asthmaticus on 13 February 1967. She was obese, her pulse rate 120/min. She was treated with intravenous A.C.T.H., oral prednisone, and ampicillin, and during the next 24 hours her condition improved. In the early hours of 15 February she awoke with sudden dyspnoea and collapsed within minutes. External cardiac massage and artificial ventilation were started promptly by the nursing staff, and intravenous sodium bicarbonate was given. Chest compression produced palpable femoral pulses, while the E.C.G. showed asystole. Five millilitres of adrenaline 1:10,000 was injected into the heart, and external massage coxntinued for a further minute. Cardiac rhythm was restored, the E.C.G. showing a supraventricular tachycardia, rate 170/min. She was intubated, and ventilated with an East Radcliffe respirator. An intravenous infusion of hydrocortisone was also given, and she made an uninterrupted recovery from this episode. She was discharged home on I March. Oral Contraceptives in the Post-partum Peiod SIR,-We wish to draw attention to some of the limitations of the paper by Dr. A. Nilsson and Mr. P.-E. Almgren on psychiatric symptoms during the post-partum period as related to the use of oral contraceptives (25 May, p. 453) . The authors conclude a causal relation between oral contraceptives and psychiatric symptoms, and that these symptoms should be ascribed to hormonal factors. Our first point concerns the observation that the group of women who take oral contraceptives in the post-partum period must show some psychological differences from the group of women who use other methods of contraception, because the first group were "more anxious to use a safe method." It might therefore be hypothesized that those women who were more anxious for reliable contraception are less able to cope with a new baby in the family, and therefore at greater risk from post-partum psychiatric symptoms-hormonal factors are not a necessary condition of the findings of this paper, and the relation is not necessarily causal. Our second point is that the choice between oral contraception and other methods is made in the post-partum period, and that is just the period during which the differences in incidence of psychiatric symptoms have been demonstrated in this paper. The possibility that oral contraception is chosen because of the high incidence of post-partum psychiatric
